Mepolizumab for treating chronic obstructive pulmonary disease [ID1237]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease [ID6235]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Virtual Wards for COPD exacerbationsStatus:Awaiting developmentProgramme:Medical technologies guidanceExpected publication date: TBC